 BOULDER, Colo.--BUSINESS WIRE--Biodesix, Inc. Nasdaq: BDSX, a leading data-driven diagnostic solutions company with a focus in lung disease, today announced that three abstracts from multiple clinical studies will be featured at the International Association for the Study of Lung Cancer IASLC World Conference on Lung Cancer WCLC, scheduled for January 28-31, 2021. Findings from these recent studies demonstrate that an individual patients immune profile can provide information to suppor 